YOUSIF M. AL-DULAIMY, W.; SHAALAN SAHAB, K.; SABRI MOHAMMED, E.; KADHOM, M. Role of blood hepcidin alteration as a biomarker in β-thalassemia patients’ diagnosis. Trends in Immunotherapy, [S. l.], v. 8, n. 1, 2024. DOI: 10.24294/ti.v8.i1.4397. Disponível em: https://ojs.ukscip.com/index.php/ti/article/view/480. Acesso em: 3 apr. 2025.